Since the launch of Max Access Solutions in 2017, The Max Foundation has delivered over 10 million daily doses of cancer treatment to patients in more than 70 low- and middle-income countries.
The majority of the cancer treatment we provide requires patients to take a daily dose. Since its inception, we have scaled the program to support more than 30,000 patients and expect to double the total number of yearly doses distributed within the next year.
“This milestone is no small achievement. Every one of the 10 million doses represents a day in the life of more than 30,000 families,” says Pat Garcia-Gonzalez, CEO of The Max Foundation. “In less than three years since the launch of Max Access Solutions, this number is a testament to the commitment of our implementing partners and donors, the determination of our team, and the resilience of our patients.”
Most recently, our global team and partners have worked hard to transition patients in India who had been receiving cancer treatment via the Glivec® International Patient Assistance Program (GIPAP) since 2002 into the umbrella of Max Access Solutions. This transition meant building new partnerships with local dispensation centers and pharmacies to ensure every patient can continue to access their treatment seamlessly.
J. Michael Wrigglesworth, The Max Foundation’s Sr. Director of Programs Strategy & Data Solutions notes this growth has been possible with our in-house online program management tool, the Patient Access Tracking System (PATS®).
“From its launch in 2017, PATS® was built to monitor and support cancer patients regardless of a patient’s location, disease, or treatment plan,” Michael says. “PATS® has the ability to easily integrate new countries, onboard treating physicians, and monitor patients around the world.”
It’s important to note that Max Access Solutions is not just a donation program, but rather, a patient access program with a broad set of activities that support each patient throughout their treatment and program lifecycle. The biggest differentiator of our program is our Patient Services, often carried out in collaboration with local patient organizations.
In India, patient support activities are carried out in partnership with the Friends of Max Trust, our local partner organization. Each year, in collaboration with Friends of Max, we host Patient Support Group meetings where patients, their families, and their caregivers can meet our team and treating physicians to ask questions and share their personal experiences. These meetings are especially vital for individuals and their families who are either facing a recent cancer diagnosis, change in treatment, or change in treating physicians.
“Reaching 10 million daily doses is just the tip of the iceberg,” said Viji Venkatesh, The Max Foundation Region Head for South Asia. “Along every dose that reaches the patient’s hands is a support system to educate patients, strengthen community, and destigmatize cancer.”
Today, as we face a global pandemic, our Patient Services have never been more vital. Our team continues to work around the clock to ensure each patient is fully supported, informed, and able to reach their treatment safely.
Lear more about our Patient Services and Max Access Solutions.
The Max Foundation (Max) is a global health nonprofit organization dedicated to accelerating health equity. For more than 25 years, Max has pioneered practical, scalable, high-quality solutions to bring lifesaving treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope. Learn more at www.themaxfoundation.org
We are delighted to announce that Bryan Murphy-Eustis, MBA, MPH, is joining The Max Foundation’s Executive Team as Vice President of Programs. Bryan joins the team with more than 18 years of experience building and leading high-impact mission-driven teams, most recently as Commercialization Lead for Medical Technologies at Global Good at Intellectual Ventures. Previously he….
The Max Foundation to launch its Max Access Solutions program for patients with HR+/HER2- advanced breast cancer in collaboration with leading oncologists in low- and middle-income countries (LMICs) and the ABC Global Alliance, the American Society for Clinical Pathology, Cepheid, and Novartis AG First patients to receive treatment in Bahamas, Benin, Bhutan, Haiti, Jamaica, Mozambique,….
Earlier this month, The Max Foundation celebrated the delivery of 110 BCR-ABL molecular tests to Mercy Medical Center Cambodia. The delivery was the first of its kind for Max, made possible through our 2018 Diagnostics Solidarity Fund. Two more deliveries – one to Kyrgyzstan and one to Bolivia – are in process now, and we’re hopeful there will be many more to come.
